-
Betrixaban (trade name Bevyxxa) is an oral
anticoagulant drug
which acts as a
direct factor Xa inhibitor.
Betrixaban is FDA
approved for
venous thrombosis...
-
inhibitor (dabigatran) and
factor Xa
inhibitor (rivaroxaban, apixaban,
betrixaban and edoxaban), and they have been
shown to be as good or
possibly better...
- Savaysa) was
approved in ****an in 2011 and in
Europe and the US in 2015.
Betrixaban (Bevyxxa) was
approved in the US in 2017.
Heparin was
discovered by Jay...
- the
authorisation (approved)
Andexanet for the 28
countries of the EU.
Betrixaban (Bevyxxa), an oral
direct FXa
inhibitor for
prevention of thrombosis;...
- (Eliquis) from Bristol-Myers Squibb,
edoxaban (Lixiana) from Daiichi, and
betrixaban (Bevyxxa) from
Portola Pharmaceuticals.
Xabans that
never reached the...
-
etexilate B01AF01
Rivaroxaban B01AF02
Apixaban B01AF03
Edoxaban B01AF04
Betrixaban B01AF51
Rivaroxaban and
acetylsalicylic acid B01AX01
Defibrotide B01AX04...
- Xa has been developed.
These include the
drugs rivaroxaban, apixaban,
betrixaban, LY517717,
darexaban (YM150),
edoxaban and 813893.
These agents have several...
-
Betimol Betnesol Betnovate Betoptic Pilo
Betoptic S
betoxycaine (INN)
betrixaban (USAN)
Bevacip Bevaciptin bevacizumab (INN) bevacizumab-adcd bevacizumab-awwb...
